SCHEMBL9939503

SCHEMBL9939503

Cc1cc(Br)c(N)c(CN[C@H]2CC[C@H](O)CC2)c1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 3/20 0.75
▸ CYP1A2 P05177 2/20 0.75
▸ SLC6A4 P31645 2/20 0.75
▸ KCNH2 Q12809 2/20 0.75
▸ LMNA P02545 2/20 0.75
▸ GBA1 P04062 1/20 0.75
▸ CNR1 P21554 1/20 0.75
▸ TBXA2R P21731 1/20 0.75
▸ HRH2 P25021 1/20 0.75
▸ HIF1A Q16665 1/20 0.75
▸ TDP1 Q9NUW8 2/20 0.73
▸ CYP3A4 P08684 2/20 0.73
▸ ALOX15 P16050 1/20 0.73
▸ TSHR P16473 1/20 0.73
▸ ALDH1A1 P00352 3/20 0.37
▸ KDM4E B2RXH2 3/20 0.37
▸ CD274 Q9NZQ7 2/20 0.36
▸ PDCD1 Q15116 1/20 0.36
▸ PABPC1 P11940 1/20 0.36
▸ MEN1 O00255 4/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ambroxol SCHEMBL18702 0.86 CYP2D6 (1.00) CYP2D6CYP1A2SLC6A4KCNH2LMNA
Ambroxol SCHEMBL423712 0.86 CYP2D6 (1.00) CYP2D6CYP1A2SLC6A4KCNH2LMNA
Ambroxol SCHEMBL29380194 0.86 CYP2D6 (1.00) CYP2D6CYP1A2SLC6A4KCNH2LMNA
Ambroxol SCHEMBL28472066 0.86 CYP2D6 (1.00) CYP2D6CYP1A2SLC6A4KCNH2LMNA
Ambroxol SCHEMBL7855003 0.86 CYP2D6 (1.00) CYP2D6CYP1A2SLC6A4KCNH2LMNA
Ambroxol SCHEMBL6601413 0.84 CYP3A4 (1.00) CYP2D6CYP1A2SLC6A4KCNH2LMNA
Ambroxol SCHEMBL99455 0.84 CYP3A4 (1.00) CYP2D6CYP1A2SLC6A4KCNH2LMNA
SCHEMBL11623963 0.84 LMNA (0.71) CYP2D6CYP1A2SLC6A4KCNH2LMNA
SCHEMBL13921508 0.83 CYP1A2 (0.56) CYP2D6CYP1A2SLC6A4KCNH2LMNA
Ambroxol SCHEMBL1648757 0.83 CYP2D6 (0.94) CYP2D6CYP1A2SLC6A4KCNH2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2200596-B1 METHOD OF TREATING GAUCHER DISEASE HOSPITAL FOR SICK CHILDREN (CA) 2012-06-13 — — EP disclosed
Send feedback